Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/16 → 31/12/18 |
Funding
- NHMRC National Health and Medical Research Council : A$47,435.00
- NHMRC National Health and Medical Research Council : A$47,435.00
Research output
- 4 Article
-
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study
Chatterton, M. L., Perez, J. K., Thai, T., Faller, J., Loo, C. K., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P. B., Glue, P., Sarma, S., Hadzi-Pavlovic, D., Dong, V., Martin, D., Mitchell, P. B., Berk, M., Carter, G., Hackett, M. & Hood, S. & 3 others, , 15 Oct 2025, In: Journal of Affective Disorders. 387, 10 p., 119502.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Citations (Scopus) -
Effect of ketamine on anxiety: Findings from the Ketamine for Adult Depression Study
Mills, N. T., Nikolin, S., Glozier, N., Barton, D., Baune, B. T., Fitzgerald, P. B., Glue, P., Sarma, S., Rodgers, A., Hadzi-Pavlovic, D., Alonzo, A., Dong, V., Martin, D., Mitchell, P. B., Berk, M., Carter, G., Hackett, M. L., Somogyi, A. A., Mihalopoulos, C. & Chatterton, M. L. & 2 others, , Sept 2025, In: British Journal of Psychiatry. 227, 3, p. 601-607 7 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Web of Science) -
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)
Martin, D. M., Harvey, A. J., Baune, B., Berk, M., Carter, G. L., Dong, V., Glozier, N., Glue, P., Hood, S., Hadzi-Pavlovic, D., Hackett, M., Mills, N., Sarma, S., Somogyi, A., Rodgers, A. & Loo, C. K., 1 May 2024, In: Journal of Affective Disorders. 352, p. 163-170 8 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Citations (Scopus)